0 CHECKOUT

PRODUCT FILTERS

REGION

128
35
26
25
19

COUNTRY

17
15
15
15
15

CATEGORIES

  • 193
  • 122
  • 101
  • 91
  • 84
  • 79
  • 76
  • 38
  • 37
  • 34
  • 33
  • 30
  • 30
  • 29
  • 29
  • 27
  • 25
  • 24
  • 23
  • 20
  • 20
  • 20
  • 19
  • 18
  • 18
  • 17
  • 16
  • 15
  • 15
  • 14
  • 12
  • 12
  • 12
  • 11
  • 10
  • 10
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

131
194
852
1,115

PUBLISHED

31
196
560
1,115

PRODUCT TYPE

916
103
82
6
5
1
1
1

Search for: "Cell Therapeutics Inc.-Therapeutic Competitors"

Cell Therapeutics Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

“Cell Therapeutics Inc. Business Profile” is a comprehensive research on the company’s operations across the value chain. The report on Cell Therapeutics Inc. analyzes the company’s key strategies,...

Published:  May 2016
Price:  From

Fate Therapeutics, Inc. - Product Pipeline Review - 2016

Fate Therapeutics, Inc. - Product Pipeline Review - 2016 Summary ‘Fate Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Fate Therapeutics, Inc.’s pharmaceutical research...

Published:  May 2016
Price:  From

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2016

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2016 Summary ‘Immunomic Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Immunomic Therapeutics, Inc.’s pharmaceutical...

Published:  February 2016
Price:  From

Brainstorm Cell Therapeutics, Inc. (USA) - Company Reports

This report presents quick facts about Brainstorm Cell Therapeutics, Inc., which is principally involved in Biotechnology Business. Illustrated with 30 tables, the report showcases the company's sales...

Published:  January 2016
Price:  From

StemCells, Inc. (USA) - Company Reports

This report presents quick facts about StemCells, Inc., which is principally involved in Stem Cell Therapeutics Business. Illustrated with 33 tables, the report showcases the company's recent news stories...

Published:  January 2016
Price:  From

World Protein Therapeutics Market - Opportunities and Forecasts, 2014 - 2022

Protein therapeutics is artificially synthesized protein on large scale through genetically modified host cells that is used in treatment of chronic diseases such as cancer, diabetes and CVD. According...

Published:  August 2016
Price:  From

Exosome Diagnostics and Therapeutics: Global Markets

This report provides an overview of the current state of the exosome industry, existing products on the market and detailed analysis of the competitive environments, including new potential markets...

Published:  March 2016
Price:  From

Renal Cell Carcinoma - Pipeline Review, H1 2016

Renal Cell Carcinoma - Pipeline Review, H1 2016 Summary ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape. The report provides...

Published:  May 2016
Price:  From

Mesenchymal Stem Cells - Advances & Applications

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells,...

Published:  November 2015
Price:  From

Sickle Cell Disease - Pipeline Review, H2 2015

Sickle Cell Disease - Pipeline Review, H2 2015 Summary The report ‘Sickle Cell Disease - Pipeline Review, H2 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Sickle Cell Disease - Pipeline Review, H1 2015

Sickle Cell Disease - Pipeline Review, H1 2015 Summary This, ‘Sickle Cell Disease - Pipeline Review, H1 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This report...

Published:  May 2015
Price:  From

Renal Cell Carcinoma - Pipeline Review, H1 2015

Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary This, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Renal Cell Carcinoma - Pipeline Review, H2 2015

Renal Cell Carcinoma - Pipeline Review, H2 2015 Summary The report ‘Renal Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks...

Published:  June 2015
Price:  From

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016 Summary ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline...

Published:  June 2016
Price:  From

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016 Summary ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape....

Published:  May 2016
Price:  From

Cesca Therapeutics Inc. (KOOL) - Product Pipeline Analysis, 2015 Update

Summary Cesca Therapeutics Inc. (Cesca) formerly ThermoGenesis Corp. is a medical equipment company. It researches, develops, and commercializes cell based therapeutics for application in regenerative...

Published:  October 2015
Price:  From

Small-Cell Lung Cancer - Pipeline Review, H1 2016

Small-Cell Lung Cancer - Pipeline Review, H1 2016 Summary ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape. The report provides...

Published:  May 2016
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. The report...

Published:  February 2016
Price:  From

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  February 2015
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group